Arginyl-glutamine dipeptide or docosahexaenoic acid attenuate hyperoxia-induced lung injury in neonatal mice

Nutrition

Volumn 28, Issue 11-12, 2012, Pages 1186-1191

  Ma, Liya ^a,b   Li, Nan ^a   Liu, Xueyan ^a,c   Shaw, Lynn ^d   Li Calzi, Sergio ^d   Grant, Maria B ^d   Neu, Josef ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Baoan Maternal and Child Health Hospital   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Arginine; Bronchopulmonary dysplasia; Dipeptide; Docosahexaenoic acid; Glutamine; Hyperoxia

Indexed keywords

ARGINYLGLUTAMINE; CXCL1 CHEMOKINE; DIPEPTIDE; DOCOSAHEXAENOIC ACID; I KAPPA B ALPHA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DIET SUPPLEMENTATION; ENTERIC FEEDING; HYPEROXIA; LUNG ALVEOLUS; LUNG DEVELOPMENT; LUNG INJURY; MOUSE; NEWBORN; NONHUMAN; NUTRITIONAL SUPPORT; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; ATMOSPHERE EXPOSURE CHAMBERS; BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; CYTOKINES; DIETARY SUPPLEMENTS; DIPEPTIDES; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; HYPEROXIA; INFANT, NEWBORN; INFLAMMATION MEDIATORS; LACTATION; LUNG; MALE; MICE; MICE, INBRED C57BL;

MUS;

EID: 84867155106     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.04.001     Document Type: Article

References (46)

1. Wemhöner A., Ortner D., Tschirch E., Strasak A., Rüdiger M. Nutrition of preterm infants in relation to bronchopulmonary dysplasia. BMC Pulm Med 2011, 11:7.
2. Van Marter L.J. Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med 2009, 14:358-366.
3. Thomas W., Speer C.P. Prevention and treatment of bronchopulmonary dysplasia: current status and future prospects. J Perinatol 2007, 27:S26-S32.
4. Sanli A., Onen A., Sarioglu S., Sis B., Guneli E., Gokcen B., et al. Glutamine administration enhances the healing of lung parenchymal injuries and reduces air leakage in rats. Tohoku J Exp Med 2006, 210:239-245.
5. Fox R.E., Hopkins I.B., Cabacungan E.T., Tildon J.T. The role of glutamine and other alternate substrates as energy sources in the fetal rat lung type II cell. Pediatr Res 1996, 40:135-141.
6. Rogers L.K., Valentine C.J., Pennell M., Velten M., Britt R.D., Dingess K., et al. Maternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice. J Nutr 2010, 141:214-222.
7. Marconi A.M., Battaglia F.C., Meschina G., Sparks J.W. A comparison of amino acid arteriovenous differences across the liver and placenta of the fetal lamb. Am J Physiol Endocrinol Metab 1989, 257:E909-E915.
8. van der Hulst R.R., van Kreel B.K., van Meyenfeldt M., Brummer R.J., Arends J.W., Deutz N.E., et al. Glutamine and the preservation of gut integrity. Lancet 1993, 341:1363-1665.
9. Newsholme E.A., Crabtree B., Ardawli M.S. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical implications. J Exp Physiol 1989, 70:473-489.
10. Khan K., Hardy G., McElroy B., Elia M. The stability of L-glutamine in total parenteral nutrition solutions. Clin Nutr 1991, 10:186-192.
11. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991, 43:109-142.
12. Wu G., Jaeger L.A., Bazer F.W., Rhoads J.M. Arginine deficiency in preterm infants: biochemical mechanisms and nutritional implications. J Nutr Biochem 2004, 14:442-451.
13. Canpolat F.E., Yurdakök M., Yiĝit S., Korkmaz A., Tekinalp G. Blood L-arginine levels in early respiratory distress syndrome. Pediatr Pulmonol 2005, 40:511-514.
14. Vosatka R.J., Kashyap S., Trifiletti R.R. Arginine deficiency accompanies persistent pulmonary hypertension of the newborn. Biol Neonate 1994, 66:65-70.
15. Becker R.M., Wu G., Galanko J.A., Chen W., Maynor A.R., Bose C.L., et al. Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr 2000, 137:785-793.
16. Lapillonne A., Jensen C.L. Reevaluation of the DHA requirement for the premature infant. Prostaglandins Leukot Essent Fatty Acids 2009, 81:143-150.
17. Driscoll D.F., Bistrian B.R., Demmelmair H., Koletzko B. Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology. Clin Nutr 2008, 27:497-508.
18. Calder P.C. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 2009, 91:791-795.
19. Furst P. New developments in glutamine delivery. J Nutr 2001, 131. 2562S-8.
20. Adibi S.A., Phillips E. Evidence for greater absorption of amino acids from peptides than from free form in the human intestine. Clin Res 1968, 16:466.
21. Neu J., Afzal A., Pan H., Gallego E., Li N., Li Calzi S., et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 2006, 47:3151-3155.
22. Husari A.W., Dbaibo G.S., Bitar H., Khayat A., Panjarian S., Nasser M., et al. Apoptosis and the activity of ceramide, Bax and Bcl-2 in the lungs of neonatal rats exposed to limited and prolonged hyperoxia. Respir Res 2006, 7:100.
23. Chetty A., Cao G.J., Severgnini M., Simon A., Warburton R., Nielsen H.C. Role of matrix metalloprotease-9 in hyperoxic injury in developing lung. Am J Physiol Lung Cell Mol Physiol 2008, 295:L584-L592.
24. Vicencio A.G., Lee C.G., Cho S.J., Eickelberg O., Chuu Y., Haddad G.G., et al. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia?. Am J Respir Cell Mol Biol 2004, 31:650-656.
25. Li N., Russell W.M., Douglas-Escobar M., Hauser N., Lopez M., Neu J. Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats. Pediatr Res 2009, 66:203-207.
26. Ogawa Y., Tasaka S., Yamada W., Saito F., Hasegawa N., Miyasho T., et al. Role of Toll-like receptor 4 in hyperoxia-induced lung inflammation in mice. Inflamm Res 2007, 56:334-338.
27. Aldridge G.M., Podrebarac D.M., Greenough W.T., Weiler I.J. The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods 2008, 172:250-254.
28. Thébaud B., Abman S.H. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 2007, 175:978-985.
29. Bin-Jaliah I., Dallak M., Haffor A.S. Effect of hyperoxia on the ultrastructural pathology of alveolar epithelium in relation to glutathione peroxidase, lactate dehydrogenase activities, and free radical production in rats, Rattus norvigicus. Ultrastruct Pathol 2009, 33:112-222.
30. Yang G., Abate A., George A.G., Weng Y.-H., Dennery P.A. Maturational differences in lung NF-κB activation and their role in tolerance to hyperoxia. J Clin Invest 2004, 114:669-678.
31. Liu Y.-Y., Liao S.-K., Huang C.-C., Tsai Y.-H., Quinn D.A., Li L.-F. Role for nuclear factor-κB in augmented lung injury because of interaction between hyperoxia and high stretch ventilation. Transl Res 2009, 154:228-240.
32. Hubert-Buron A., Leblond J., Jacquot A., Ducrotté P., Déchelotte P., Coëffier M. Glutamine pretreatment reduces IL-8 production in human intestinal epithelial cells by limiting IkappaB alpha ubiquitination. J Nutr 2006, 136:1461-1465.
33. Singleton K.D., Wischmeyer P.E. Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Physiol 2007, 292:R1839-R1845.
34. Curi R., Lagranha C.J., Doi S.Q., Sellitti D.F., Procopio J., Pithon-Curi T.C., et al. Molecular mechanisms of glutamine action. J Cell Physiol 2005, 204:392-405.
35. Musiek E.S., Brooks J.D., Joo M., Brunoldi E., Porta A., Zanoni G., et al. Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. J Biol Chem 2008, 283:19927-19935.
36. Warner B.B., Stuart L.A., Papes R.A., Wispé J.R. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol Lung Cell Mol Physiol 1998, 275:L110-L117.
37. Ogunlesi F., Cho C., McGrath-Morrow S.A. The effect of glutamine on A549 cells exposed to moderate hyperoxia. Biochim Biophys Acta 2004, 1688:112-220.
38. Dallas M.J., Bowling D., Roig J.C., Auestad N., Neu J. Enteral glutamine supplementation for very-low-birth-weight infants decreases hospital costs. J Parenter Enteral Nutr 1998, 22:352-356.
39. Neu J., Roig J.C., Meetze W.H., Veerman M., Carter C., Millsaps M., et al. Enteral glutamine supplementation for very low birth weight infants decreases morbidity. J Pediatr 1997, 131:691-699.
40. Lacey J.M., Crouch J.B., Benfell K., Ringer S.A., Wilmore C.K., Maguire D., et al. The effects of glutamine-supplemented parenteral nutrition in premature infants. J Parenter Enteral Nutr 1996, 20:74-80.
41. van Zwol A., Neu J., van Elburg R.M. Long-term effects of neonatal glutamine-enriched nutrition in very-low-birth-weight infants. Nutr Rev 2011, 69:2-8.
42. Amin H.J., Zamora S.A., McMillan D.D., Fick G.H., Butzner J.D., Parsons H.G., et al. Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr 2002, 140:425-431.
43. Mataloun M.M., Leone C.R., Mascaretti R.S., Dohlnikoff M., Rebello C.M. Effect of postnatal malnutrition on hyperoxia-induced newborn lung development. Braz J Med Biol Res 2009, 42:606-613.
44. De Paepe M.E., Mao Q., Powell J., Rubin S.E., DeKoninck P., Appel N., et al. Growth of pulmonary microvasculature in ventilated preterm infants. Am J Respir Crit Care Med 2006, 173:204-211.
45. Kinsella J.P., Greenough A., Abman S.H. Bronchopulmonary dysplasia. Lancet 2006, 367:1421-1431.
46. Speer C.P. Pulmonary inflammation and bronchopulmonary dysplasia. J Perinatol 2006, 26:S57-S62.